← Open Payments lookup

KAMALJEET GILL: Open Payments

NPI 1285351528 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,328 in 97 payments from 23 companies in 2025. Trend: 2023 $904 · 2024 $2,049 · 2025 $2,328

Food & beverage: $2,328
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$298
Regeneron Healthcare Solutions, Inc.9$284
Boehringer Ingelheim Pharmaceuticals, Inc.9$235
Lilly USA, LLC6$230
Amgen Inc.17$171
Verona Pharma, Inc.5$150
GlaxoSmithKline, LLC.12$149
Novo Nordisk Inc1$125
GENZYME CORPORATION4$90
United Therapeutics Corporation3$79

Products named: DUPIXENT, TEZSPIRE, MOUNJARO, Ohtuvayre, TRELEGY ELLIPTA, AIRSUPRA, Ozempic, Tyvaso.

Industry payments across CA — which companies pay providers there.